Global HPV associated disorder market is projected to grow at a considerable CAGR of around 5% during the forecast period (2020-2026). The high incidence and prevalence of HPV associated disorder in association with the high penetration of medication is a key aspect contributing to the growth of the global HPV associated disorder market. Cohesive government policies, increasing per capita healthcare expenditure and increase in awareness programs related to HPV associated disorder are further contributing towards the high growth of the global HPV associated disorder market.